Wells Fargo & Co Trims Solaris Oilfield Infrastructure (NYSE:SOI) Target Price to $17.00

Share on StockTwits

Solaris Oilfield Infrastructure (NYSE:SOI) had its target price lowered by analysts at Wells Fargo & Co from $19.00 to $17.00 in a report issued on Thursday, BenzingaRatingsTable reports. The firm presently has an “outperform” rating on the stock. Wells Fargo & Co‘s target price indicates a potential upside of 25.09% from the company’s current price.

A number of other research analysts have also weighed in on the stock. TheStreet lowered shares of Solaris Oilfield Infrastructure from a “b-” rating to a “c” rating in a research note on Friday, May 31st. Imperial Capital reissued an “outperform” rating and issued a $22.00 target price (up from $20.00) on shares of Solaris Oilfield Infrastructure in a research note on Thursday, August 1st. ValuEngine lowered shares of Solaris Oilfield Infrastructure from a “sell” rating to a “strong sell” rating in a research note on Tuesday, July 2nd. Citigroup assumed coverage on shares of Solaris Oilfield Infrastructure in a research note on Tuesday, July 16th. They issued a “neutral” rating and a $15.00 target price on the stock. Finally, Cowen reissued an “outperform” rating and issued a $18.00 target price (down from $21.00) on shares of Solaris Oilfield Infrastructure in a research note on Thursday, August 1st. Two analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $19.50.

Solaris Oilfield Infrastructure stock traded down $0.33 during midday trading on Thursday, reaching $13.59. The company had a trading volume of 135,501 shares, compared to its average volume of 484,931. The company has a market capitalization of $662.30 million, a P/E ratio of 8.04, a P/E/G ratio of 1.00 and a beta of 1.78. Solaris Oilfield Infrastructure has a 12-month low of $10.50 and a 12-month high of $19.31. The firm’s fifty day simple moving average is $13.60 and its 200-day simple moving average is $15.44. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.63 and a quick ratio of 2.38.

Solaris Oilfield Infrastructure (NYSE:SOI) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $0.44 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.02). The company had revenue of $64.10 million during the quarter, compared to analysts’ expectations of $58.25 million. Solaris Oilfield Infrastructure had a net margin of 22.08% and a return on equity of 25.82%. The company’s quarterly revenue was up 35.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.42 earnings per share. On average, analysts expect that Solaris Oilfield Infrastructure will post 1.71 EPS for the current fiscal year.

In other Solaris Oilfield Infrastructure news, insider Christopher M. Powell sold 29,418 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $13.36, for a total value of $393,024.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director James R. Burke sold 5,641 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $13.45, for a total transaction of $75,871.45. The disclosure for this sale can be found here. Company insiders own 14.18% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the company. NumerixS Investment Technologies Inc acquired a new stake in shares of Solaris Oilfield Infrastructure during the 2nd quarter worth approximately $57,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in shares of Solaris Oilfield Infrastructure during the 2nd quarter worth approximately $67,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Solaris Oilfield Infrastructure during the 2nd quarter worth approximately $74,000. Bank of Montreal Can increased its holdings in shares of Solaris Oilfield Infrastructure by 36.6% during the 1st quarter. Bank of Montreal Can now owns 5,118 shares of the company’s stock worth $84,000 after buying an additional 1,371 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its holdings in shares of Solaris Oilfield Infrastructure by 186,066.7% during the 1st quarter. BNP Paribas Arbitrage SA now owns 5,585 shares of the company’s stock worth $92,000 after buying an additional 5,582 shares during the last quarter. Institutional investors and hedge funds own 67.00% of the company’s stock.

Solaris Oilfield Infrastructure Company Profile

Solaris Oilfield Infrastructure, Inc manufactures and rents mobile proppant and chemical management systems to unload, store, and deliver proppant and chemicals at oil and natural gas well sites in the United States. Its systems to transfer large quantities of proppant and chemicals to the well sites.

Further Reading: Why do analysts give a neutral rating?

Analyst Recommendations for Solaris Oilfield Infrastructure (NYSE:SOI)

Receive News & Ratings for Solaris Oilfield Infrastructure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Oilfield Infrastructure and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Atlassian  Upgraded at BidaskClub
Atlassian Upgraded at BidaskClub
S & T Bancorp  Raised to Hold at Zacks Investment Research
S & T Bancorp Raised to Hold at Zacks Investment Research
Scientific Games  Rating Lowered to Sell at ValuEngine
Scientific Games Rating Lowered to Sell at ValuEngine
Wingstop  Downgraded by BidaskClub
Wingstop Downgraded by BidaskClub
Encompass Health  Research Coverage Started at Deutsche Bank
Encompass Health Research Coverage Started at Deutsche Bank
Critical Contrast: PlusTherapeuticsInc   .  vs. Stryker
Critical Contrast: PlusTherapeuticsInc . vs. Stryker


 
© 2006-2019 Zolmax.